The Coalition on Abortion/Breast Cancer applauds the breast cancer group, Susan G. Komen for the Cure, for discontinuing its grants to Planned Parenthood (PP) while the abortion provider is under investigation by Congress.  Komen said it will not resume payment of the grants unless PP is exonerated. Komen attributed its decision to a new policy that prohibits grants from going to organizations under investigation by governmental authorities.

“Our group will remain as Komen’s critic as long as it continues to work against its own mission to eradicate breast cancer. Komen’s decision is a step in the right direction to protect women’s lives. However, I will not donate to Komen while it is still cooperating in the cover-up of the abortion-breast cancer link and downplaying the risk of using oral contraceptives (OCs).” asserted Karen Malec, president of the Coalition on Abortion/Breast Cancer.

“PP is a primary cause of the breast cancer epidemic. It sells cancer-causing abortions and oral contraceptives (OCs), also called “the birth control pill.”  Medical texts reveal that increased childbearing, especially starting early before age 24, substantially reduces lifetime breast cancer risk. Abortion not only deprives women of this protection, but 52 of 68 epidemiological studies show it raises breast cancer risk.[1] The World Health Organization lists OCs containing estrogen and progesterone on its list of Group 1 carcinogens – the highest level as a cancer-causing agent. [2]   OCs are associated with the deadly triple-negative breast cancer. [3,4]   Komen and the Institute of Medicine had an opportunity to reduce the incidence of breast cancer with its December 2011 study, “Breast Cancer and the Environment,” but they chose not to review reproductive risk factors and include avoidance of abortion and OCs among the ways to prevent the disease. We sincerely hope Komen will develop the political courage needed to fulfill its mission.

“PP has done substantial harm to women’s health. Additionally, PP does not do mammograms, although PP president Cecile Richards had led the public to believe otherwise.

“The Coalition on Abortion/Breast Cancer was the first to expose the Komen-PP relationship to the world in 2003. We thank our supporters for doing such a marvelous job by contacting Komen and stating their objections to this irregular relationship, and we remind them their work is not yet done. Contact Komen at ww5.komen.org/Contact.aspx. Politely thank Komen’s representatives for temporarily halting its gifts to Planned Parenthood. Ask them to permanently halt their grants to PP and tell the full truth about the breast cancer risks associated with induced abortion and oral contraceptives.”

The Coalition on Abortion/Breast Cancer is an international women’s organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.

References:

1. See the Breast Cancer Prevention Institute’s website for a complete list of all epidemiological studies and the odds ratios reported for each at: http://bcpinstitute.org/epidemiology_studies_bcpi.htm

2. Cogliano V, Grosse Y, Baan R, Secretan B, El Ghissassi F. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncology 2005;6:552-553.

3. Dolle J, Daling J, White E, Brinton L, Doody D, et al. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 2009;18(4)1157-1166. Available at: http://www.abortionbreastcancer.com/download/Abortion_Breast_Cancer_Epid_Bio_Prev_2009.pdf

4. Ma H, Wang Y, Sullivan-Halley J, Weiss, L, Marchbanks, PA, et al. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the Women’s Contraceptive and Reproductive Experiences Study. Cancer Research 2010;70(2):575-587.

Experts privately acknowledge abortion-breast cancer link, but say it’s too political to discuss publicly.

The Coalition on Abortion/Breast Cancer announced that three experts will be available for interviews to discuss the impact of the abortion-breast cancer (ABC) link on the Roe v. Wade generation during the month of January. Their contact information and their quotes are available below.

Karen Malec, the Coalition’s president, said, “During the last 21 months, four epidemiological studies and one review reported an ABC link. [1-5] One study included National Cancer Institute branch chief  Louise Brinton as co-author. [3] We count nearly 50 published epidemiological studies since 1957 reporting a link. Biological and experimental studies also support it.

“Experts proved in medical journals that nearly all of the roughly 20 studies denying the link are seriously flawed (fraudulent). Like the tobacco-cancer cover-up, these are used to snow women into believing abortion is safe.” [6-16]

Professor Joel Brind and his colleagues reported a “30% greater chance of developing breast cancer” in their 1996 review and meta-analysis of worldwide data. [17] He said recently:

“If we take the overall risk of breast cancer among women to be about 10% (not counting abortion), and raise it by 30%, we get 13% lifetime risk. Using the 50 million abortions since Roe v. Wade figure, we get 1.5 million excess cases of breast cancer. At an average mortality of 20% since 1973, that would mean that legal abortion has resulted in some 300,000 additional deaths due to breast cancer since Roe v. Wade.”

Brind said his estimate excludes deaths from the use of abortion to delay first full term pregnancies – a recognized breast cancer risk.

In 2002, Angela Lanfranchi, MD testified under oath in a California lawsuit against Planned Parenthood that she had private conversations with leading experts who agreed abortion raises breast cancer risk, but they refused to discuss it publicly, saying it was “too political.”

Contact information:

Karen Malec – (847) 421-4000 (Available through January 23 only)

Joel Brind, Ph.D. – (914) 805-9215

Angela Lanfranchi, MD – 1-86-NO-CANCER